American International Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

American International Group’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$41K	–	3307
2022 Q1	$41K	Sell	13 -1	-7%	-$4.3K	﹤0.01%	2913
2021 Q4	$85K	Hold	14	–	–	﹤0.01%	2789
2021 Q3	$130K	Buy	14 +3	+27%	+$25.8K	﹤0.01%	2672
2021 Q2	$112	Buy	+11	New	+$181K	﹤0.01%	2839
2016 Q2	–	Hold	0	–	-$3K	–	4552
2016 Q1	–	Hold	0	–	–	–	4834
2015 Q4	–	Hold	0	–	–	–	4667
2015 Q3	–	Hold	0	–	–	–	4528
2015 Q2	–	Hold	0	–	–	–	4575
2015 Q1	–	Hold	0	–	–	–	4498
2014 Q4	–	Hold	0	–	–	–	4655
2014 Q3	–	Hold	0	–	–	–	4559
2014 Q2	–	Hold	0	–	–	–	4408
2014 Q1	–	Hold	0	–	–	–	4338
2013 Q4	–	Hold	0	–	–	–	4199
2013 Q3	–	Hold	0	–	–	–	4210
2013 Q2	–	Hold	0	–	–	–	4053

Other funds holding SEEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's SEEL Position: Q2 2022 in Review

American International Group sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2022, closing a stake of 13 shares — an estimated $41K sold.

American International Group first reported a position in SEEL in Q2 2021 and held it in 4 quarters. The position peaked at $130K in Q3 2021. 65 funds tracked by Wall St. Rank hold SEEL as of Q2 2022.

American International Group reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
American International Group sold 13 Seelos Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $41K.
American International Group first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
American International Group's Seelos Therapeutics, Inc. Common Stock position peaked at $130K in Q3 2021.
65 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.